NAC N-Acetylcysteine 600 mg by Foster Regal — Ingredients, Evidence & Safety

🟢 100/100

This product looks safe

No ingredients exceed tolerable upper intake levels
100% of ingredients have research evidence

A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size

60 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

N-Acetyl Cysteine

600 mg

📊 Market median: 600.0mg (7 products) 📚 39 studies (Tier A: 2, B: 13)

This product: 600mg

Other Ingredients

k-Gelatin natural Peppermint flavor Magnesium Stearate Cellulose

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (96% of products) Structure/Function (81% of products) Nutrient (19% of products) No Claim (3% of products)

Target Groups

Adult (18 - 50 Years) Kosher Gluten Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 1 capsule daily.

⚠️ Warnings & Precautions

Tamper Evident: Do not use this product if imprinted foil seal under cap is broken or missing.

Keep out of reach of children.

Caution: If you are pregnant or nursing, consult your physician before taking this product.

🧪 Formulation Notes

Mfg. in an FDA Registered Facility using Good Manufacturing Practices (GMPs)

Antioxidant Neutralizes Cell Damaging Free Radicals

Gluten Free

Made in USA

Ko Kosher Service This product certified KO Kosher

Additional Information

Conforms to USP <2091> for weight. Meets USP <2040> disintegration for maximum bioavailability.

Keep tightly closed. Store at room temperature: 59 degrees - 86 degrees F (15 degrees to 30 degrees C).

Ko Kosher Service

Product Details

UPC / SKU 3 64175 71860 4

DSLD Entry Date 2023-12-14

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand Foster Regal

DSLD ID 297008

Data Updated 2026-04-11

Research Evidence

41 Research Sources

51 Avg Quality Score

19 Rct

13 Meta Analysis

9 Clinical Trial

B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication

Meta Analysis The Cochrane database of systematic reviews 2019

PubMed DOI

B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial

Rct Nature communications 2024

PubMed DOI

B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis

Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015

PubMed DOI

B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

Rct BMC medicine 2019

PubMed DOI

B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis

Meta Analysis General hospital psychiatry 2024

PubMed DOI

B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates

Meta Analysis The Cochrane database of systematic reviews 2006

PubMed

B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials

Meta Analysis Bipolar disorders 2021

PubMed DOI

B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials

Meta Analysis Psychopharmacology 2020

PubMed DOI

B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses

Meta Analysis Archivos de bronconeumologia 2024

PubMed DOI

View all evidence for Nac →